YLR

(3aR,4S,9bS)-4-(naphthalen-1-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide

Created:	2023-12-05
Last modified:	2024-02-21

Find Related PDB Entry
1 entries where YLR is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	47
Chiral Atom Count	3
Bond Count	51
Aromatic Bond Count	17

2D diagram of YLR

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(3aR,4S,9bS)-4-(naphthalen-1-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide
Systematic Name (OpenEye OEToolkits)	(3~{a}~{R},4~{S},9~{b}~{S})-4-naphthalen-1-yl-3~{a},4,5,9~{b}-tetrahydro-3~{H}-cyclopenta[c]quinoline-8-sulfonamide
Formula	C₂₂ H₂₀ N₂ O₂ S
Molecular Weight	376.471
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	NS(=O)(=O)c1ccc2NC(C3CC=CC3c2c1)c1cccc2ccccc21
SMILES	CACTVS	3.385	N[S](=O)(=O)c1ccc2N[CH]([CH]3CC=C[CH]3c2c1)c4cccc5ccccc45
SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)cccc2C3C4CC=CC4c5cc(ccc5N3)S(=O)(=O)N
Canonical SMILES	CACTVS	3.385	N[S](=O)(=O)c1ccc2N[C@@H]([C@@H]3CC=C[C@@H]3c2c1)c4cccc5ccccc45
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)cccc2[C@@H]3[C@@H]4CC=C[C@@H]4c5cc(ccc5N3)S(=O)(=O)N
InChI	InChI	1.06	InChI=1S/C22H20N2O2S/c23-27(25,26)15-11-12-21-20(13-15)17-8-4-10-19(17)22(24-21)18-9-3-6-14-5-1-2-7-16(14)18/h1-9,11-13,17,19,22,24H,10H2,(H2,23,25,26)/t17-,19+,22+/m0/s1
InChIKey	InChI	1.06	SIZWDJIHABLBSP-LRXVAGHRSA-N

Related Resource References

Resource Name	Reference
PubChem	6553995

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.